The potential role of mesenchymal stem cells in modulating antiageing process
- 10 July 2021
- journal article
- review article
- Published by Wiley in Cell Biology International
- Vol. 45 (10) , 1999-2016
Abstract
Ageing and age‐related diseases share some basic origin that largely converges on inflammation. Precisely, it boils down to a common pathway characterised by the appearance of a fair amount of proinflammatory cytokines known as inflammageing. Among the proposed treatment for antiageing, MSCs gained attention in recent years. Since mesenchymal stem cells (MSCs) can differentiate itself into a myriad of terminal cells, previously it was believed that these cells migrate to the site of injury and perform their therapeutic effect. However, with the more recent discovery of huge amounts of paracrine factors secreted by MSCs, it is now widely accepted that these cells do not engraft upon transplantation but rather unveil their benefits through excretion of bioactive molecules namely those involved in inflammatory and immunomodulatory activities. Conversely, the true function of these paracrine changes has not been thoroughly investigated all these years. Hence, this review will describe in detail on ways MSCs may capitalize its paracrine properties in modulating antiageing process. Through a comprehensive literature search various elements in the antiageing process, we aim to provide a novel treatment perspective of MSCs in antiageing related clinical conditions.Keywords
This publication has 160 references indexed in Scilit:
- The Hallmarks of AgingCell, 2013
- Expression of the Chitinase Family Glycoprotein YKL-40 in Undifferentiated, Differentiated and Trans-Differentiated Mesenchymal Stem CellsPLOS ONE, 2013
- Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cellsImmunology & Cell Biology, 2013
- Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell ApoptosisCell Stem Cell, 2012
- The Biology of Aging and FrailtyClinics in Geriatric Medicine, 2011
- Why is osteoarthritis an age-related disease?Best Practice & Research Clinical Rheumatology, 2010
- IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft versus host diseaseEuropean Journal of Immunology, 2008
- Autophagy in the Pathogenesis of DiseaseCell, 2008
- Adiponectin as an anti-inflammatory factorClinica Chimica Acta, 2007
- Distribution of ICAM-1 immunoreactivity during aging in the human orbitofrontal cortexBrain, Behavior, and Immunity, 2007